Detalhe da pesquisa
1.
Overlapping features of therapy-related and de novo NPM1-mutated AML.
Blood
; 141(15): 1846-1857, 2023 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36508705
2.
CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome.
Blood
; 139(1): 87-103, 2022 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320176
3.
Prediction of complete remission and survival in acute myeloid leukemia using supervised machine learning.
Haematologica
; 108(3): 690-704, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35708137
4.
Use of Minimal Residual Disease in Acute Myeloid Leukemia Therapy.
Curr Treat Options Oncol
; 21(1): 8, 2020 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32002673
5.
EZH2 mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia.
Haematologica
; 105(5): e228-e231, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31413097
6.
Mimicking clinical trials with synthetic acute myeloid leukemia patients using generative artificial intelligence.
NPJ Digit Med
; 7(1): 76, 2024 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38509224
7.
Prognostic impact of CEBPA mutational subgroups in adult AML.
Leukemia
; 38(2): 281-290, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38228680
8.
Adaptation of the hydrocarbonoclastic bacterium Alcanivorax borkumensis SK2 to alkanes and toxic organic compounds: a physiological and transcriptomic approach.
Appl Environ Microbiol
; 79(14): 4282-93, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23645199
9.
Retained functional normal and preleukemic HSCs at diagnosis are associated with good prognosis in DNMT3AmutNPM1mut AMLs.
Blood Adv
; 7(6): 1011-1018, 2023 03 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36453648
10.
Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome.
Blood Cancer J
; 13(1): 18, 2023 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36693840
11.
Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia.
Leukemia
; 37(12): 2395-2403, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37833543
12.
Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles.
Commun Med (Lond)
; 3(1): 68, 2023 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37198246
13.
UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome.
Blood Cancer J
; 13(1): 88, 2023 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37236968
14.
Analysis of Subset Chimerism for MRD-Detection and Pre-Emptive Treatment in AML.
Front Oncol
; 12: 841608, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35252010
15.
Prevalence and variation of CHIP in patients with aggressive lymphomas undergoing CD19-directed CAR T-cell treatment.
Blood Adv
; 6(6): 1941-1946, 2022 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008107
16.
Deep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AML.
Blood Adv
; 6(11): 3294-3303, 2022 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35320339
17.
Point Mutations in the FLT3-ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant KMT2A-PTD.
Front Oncol
; 12: 862991, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35387132
18.
Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations.
J Hematol Oncol
; 15(1): 60, 2022 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35562747
19.
Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation.
J Hematol Oncol
; 15(1): 126, 2022 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36064577
20.
Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study.
Blood Adv
; 6(5): 1394-1405, 2022 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34794176